Details for 2012850255
Up to date per 21.04.2026
Actions
Details for 2012850255
Deleted
European Patent
24.09.2014 A
16.08.2017 B1
18.11.2011
US
201161561710 P
26.03.2012
US
201261615618 P
06.08.2012
US
201261680098 P
C12N 15/11 20060101AFI20150504BHEP
Owner
Alnylam Pharmaceuticals, Inc.300 Third Street, 3rd Floor Cambridge, MA 02142US
Representative
No representatives present
Inventor
RAJEEV, Kallanthottathil, G.300 Third Street 3rd Floor Cambridge, MA 02142US
ZIMMERMANN, Tracy300 Third Street 3rd Floor Cambridge, MA 02142US
MANOHARAN, Muthiah300 Third Street 3rd Floor Cambridge, MA 02142US
MAIER, Martin300 Third Street 3rd Floor Cambridge, MA 02142US
KUCHIMANCHI, Satyanarayana300 Third Street 3rd Floor Cambridge, MA 02142US
CHARISSE, Klaus300 Third Street 3rd Floor Cambridge, MA 02142US